Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
Abstract Background Therapeutic options for ulcerative colitis (UC) have increased since the introduction of biologics a few decades ago. Due to the wide range of biologics available, physicians have difficulty in selecting biologics and do not know how to balance the best drug between clinical effi...
Main Authors: | Xinqiao Chu, Yaning Biao, Chengjiang Liu, Yixin Zhang, Chenxu Liu, Ji-zheng Ma, Yufeng Guo, Yaru Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-023-02938-6 |
Similar Items
-
Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
by: Toshifumi Hibi, et al.
Published: (2021-01-01) -
Pharmacological effects of berberine on models of ulcerative colitis: A meta-analysis and systematic review of animal studies
by: Shuangyuan Hu, et al.
Published: (2022-09-01) -
Efficacy of integrated traditional Chinese and Western medicine on ulcerative colitis: A systematic review and meta-analysis
by: Si-min Chen, et al.
Published: (2022-09-01) -
Medium to long-term efficacy and safety of oral tacrolimus in moderate to severe steroid refractory ulcerative colitis
by: Raúl Vicente Olmedo-Martín, et al. -
Preclinical evidence of probiotics in ulcerative colitis: a systematic review and network meta-analysis
by: Wenqin Jin, et al.
Published: (2023-06-01)